Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX-8998 for Tremor in Parkinson's Disease
NCT03436953Phase 2Withdrawn
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of suvecaltamide in Parkinson's disease (PD), sponsored by Jazz Pharmaceuticals plc. Planned start Dec 2019; status: withdrawn.
02
Drugs
suvecaltamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03436953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436953.